Access to financial services acts as a catalyst for more inclusive growth. Financial inclusion is a major strategy in achieving the United Nations Sustainable Development Goals "SDGs". Symbiotics is responding to this increasing need for financial inclusion, contributing primarily to SDG 1: No Poverty, SDG 5: Gender Equality and SDG 8: Decent Work and Economic Growth, as well as other SDGs via specialized institutions.
MEDIAN AVERAGE LOAN
END BORROWERS REACHED
2022 IN NUMBERS
By investing in 85 specialized investees, we estimate that the fund has contributed to supporting 10 million jobs, primarily through providing loans to small and medium-sized enterprises "SMEs" in developing and emerging markets.
Symbiotics continues to direct investments towards regions where access to finance remains a significant challenge. In the Symbiotics investee countries, only about 60% of individuals have a bank account in a financial institution, a number Symbiotics hopes to increase through its investments.
Symbiotics is reaching over 300 entities through its portfolio, with the majority being financial institutions. Additionally, it includes innovative business models such as renewable energy companies, agricultural cooperatives, and fintechs.
Symbiotics invested the largest volumes in Latin America & the Caribbean (30.8% of the outstanding portfolio), followed by South & East Asia (28.4%), Eastern Europe, Central Asia & MENA (23.8%), and finally sub-Saharan Africa (13.5%).The top three countries of investment were India, Ecuador and Costa Rica, all together representing 20.3% of the firm’s exposure.
Erva Novaria, MBK, Indonesia
Discover Erva Novaria's inspiring journey from cashier to street vendor, backed by microfinancing in pandemic-struck Indonesia.
Ximena Toro, COAC CACPECO, Ecuador
From opening an optical store to facing pandemic trials, explore Ximena Toro's entrepreneurial spirit in Quito, bolstered by COAC CACPECO.
2023 REPORT NOW AVAILABLE
The figures presented in this report are the average quarterly figures for the reporting period (April 2022 to March 2023) unless indicated otherwise.